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Introduction
Epidemiological evidence for a genetic contribution to CD is 
clear-cut; 15% of patients with CD have an affected family mem-
ber with IBD giving a relative risk to siblings of (λ)17x population 
risk. In addition, twin studies for CD have shown approximately 
50% concordance in monozygotic twins compared to less than 
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10% dizygotics.2 The most widely accepted model is one in which 
a genetically susceptible host encounters an environmental bacte-
rial or viral agent, triggering a breach of the intestinal epithelial 
barrier which separates the lumenal contents and microbial flora 
from the mucosal immune system. This primary event may lead 
to inflammatory flares in the gut mucosa. Subsequently, failures 
to properly downregulate the immunological response and estab-
lish epithelial restitution and repair leave the gut primed for future 
flare-ups, perhaps triggered by progressively less significant envi-
ronmental insults. Crohn disease is characterized by discontinu-
ous areas of inflammation in the distal small intestine and colon. 
The distinguishing features of inflammation in CD are that it is 
transmural and includes frequent lymphoid aggregates that are 
present even in the outer muscle layer and mesothelial lining as 
well as non-caseating granulomas composed of fused monocyte-
derived cells. The transmural inflammation in CD is significant 
as it is associated with fistula formation with adjacent tissues. 
Features that distinguish ulcerative colitis (UC) include diffuse 
inflammation mostly confined to the inner layer (the mucosa) of 
the colon. The inflammation tends to be confluent and extends 
proximally from the rectum to a varying degree throughout the 
colon and is characterized by a complex mixture of inflammatory 
cells. In the last decade substantial advances in the understanding 
of the molecular pathogenesis of CD has been made as a result 
of multiple related lines of investigation. Importantly, CD has 
been one of the most tractable multigenic disorders for discovery 
of susceptibility genes. The genetic associations identified in CD 
suggest that multiple cell types and pathways are involved in gen-
erating the disease phenotype. These new discoveries have under-
scored the importance of epithelial barrier function, cell specific 
microbial responses (autophagy, ER stress, phagocytosis), innate 
(NOD proteins, inflammasome associated NALP3) and adaptive 
immunity (IL23R/Th17 cells) in disease pathogenesis.
Early work in the study of IBD inflammation focused upon 
alterations in the activation states of T cells (Th1, Th2 or more 
Crohn disease (CD) is a chronic and debilitating inflamma-
tory condition of the gastrointestinal tract.1 Prevalence in west-
ern populations is 100–150/100,000 and somewhat higher in 
Ashkenazi Jews. Peak incidence is in early adult life, although 
any age can be affected and a majority of affected individu-
als progress to relapsing and chronic disease. Medical treat-
ments rely significantly on empirical corticosteroid therapy 
and immunosuppression, and intestinal resectional surgery 
is frequently required. Thus, 80% of patients with CD come to 
surgery for refractory disease or complications. It is hoped that 
an improved understanding of pathogenic mechanisms, for 
example by studying the genetic basis of CD and other forms 
of inflammatory bowel diseases (IBD), will lead to improved 
therapies and possibly preventative strategies in individuals 
identified as being at risk.
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is the induction of local and systemic tolerance, often character-
ized as oral tolerance.18 From this vantage point, one potential 
model of IBD disease pathogenesis is that a dysregulated innate 
immune response to intestinal microbes occurs in genetically sus-
ceptible individuals. Abnormal cytokine responses are features of 
both CD and UC, although the model of CD as a T helper, Th1 
driven illness and UC as a Th2 bias response now appears overly 
simplistic with an emerging role imbalance between the Th17 
lineage producing IL-23 and IL-17 and regulatory T/B cells in 
both diseases.
In this review, experts in genetics, mucosal immunity and 
autophagy provide an up-to-date perspective on Crohn disease.
Genome-Wide Association Studies Reveal  
an Unexpected Role of Autophagy in Crohn Disease
The last three years have seen dramatic progress in understand-
ing the genetic basis of CD and UC. This is due, in large part, 
to comprehensive genetic studies of DNA samples from large 
cohorts of patients and matched controls for over 300,000 genetic 
variants spread across the human genome. These studies, known 
as genome-wide association (GWA) studies, enable the examina-
tion of the majority of common genetic variation for roles in dis-
ease susceptibility. Given that the genetic variants tested in GWA 
studies are spread throughout the genome, rather than selected to 
test a specific set of genes, these studies have proven invaluable in 
identifying biological pathways not previously suspected of play-
ing a role in a disease’s pathogenesis. In the following sections, we 
will recount how GWA studies have revealed a key role for auto-
phagy in CD and place these discoveries in the broader context 
of IBD genetics and pathophysiology.
For many years, investigators used affected sibling pair tech-
niques of linkage analysis to try to localize IBD susceptibility 
genes. Although limited by the intrinsically poor resolution of 
this method for pinpointing individual genes, some success was 
achieved using association-based methodologies to fine-map 
within linkage intervals. The major success in CD, and indeed 
one of the few successes across the spectrum of complex disease, 
was the strong association identified with relatively rare variants 
of the NOD2 gene. This flagged for the first time the importance 
of defects in innate immunity as a key pathogenic mechanism 
in IBD.
Nod2 is expressed intracellularly, particularly in monocytes 
and Paneth cells, and encodes an intracellular receptor for mur-
amyl dipeptide (MDP), a motif present in bacterial cell walls. 
Although its exact function has yet to be determined, Nod2 
appears to play an important role in innate immunity in modu-
lating signaling through Toll-like receptor pathways and acti-
vating NFκB. Nod2 may also act as a sensor for intracellular 
bacteria by triggering autophagy as they enter the cell.19,20 One 
conundrum is that the NOD2 variants associated with CD result 
in loss of function of the Nod2 protein, begging the question as 
to how reduced activity of a key component of an innate immune 
pathway can lead to an increase in inflammatory activity. Perhaps 
the most plausible theories suggest that adaptive immune mech-
anisms may be recruited due to the defective innate immune 
recently Th17) and the resultant cytokine profiles that occur in 
various forms of IBD. However, recent advances have focused on 
the role of the innate immune system in initiating, modulating 
and perhaps driving the abnormal inflammatory response that 
occurs in IBD. Murine models of IBD have proved an important 
tool to uncover the key pathways and innate cell types that play 
a role in the pathogenesis/mucosal immunopathology of IBD. 
In particular, efforts directed towards the identification of envi-
ronmental factors implicate gut resident commensal microbiota 
rather than pathogens as drivers of dysregulated immunity and 
susceptibility to IBD. Commensal enteric bacteria are crucial 
for development of the host immune system and intestinal epi-
thelial cell repair and homeostasis,3-5 but they are also a critical 
factor in determining the induction and the course of IBD as 
indicated by the absence of colitis in several mouse IBD models 
when they are derived as germ-free.6 In IBD patients, diversion 
of the fecal stream is associated with improvement in CD7 and 
some IBD patients improve upon intestinal washes or antibiotic 
treatment.8-10 Alternatively, administration of probiotic bacteria 
may contribute to the suppression of colitis.8,9 One theory of 
IBD is that it involves dysregulation of the normal co-evolved 
homeostatic relationships between the gut microbiota and the 
host immune system. The identification of such perturbations 
and how to effect their restoration is key to understanding the 
pathogenesis of IBD and routes to therapy.
The intestinal microbiota is comprised of more than 1,000 
species of bacteria, which in the colon reach densities of more 
than 10,12 organisms per milliliter of lumenal content.11,12 
Indeed, the lumenal contents of the colon account for 99.9% 
of the known human indigenous microbiota.13 Indigenous 
bacteria colonize mucosal surfaces and the gastrointestinal 
tract at birth in a pattern that resembles ecological succes-
sion,14 which reaches climax early in childhood.13 The adult 
microbiota for each individual is unique and stable over time, 
as shown by culture-independent small subunit ribosomal 
RNA gene-based assays.15,16
IBD patients have an altered lumenal- and mucosal-associated 
microbiome, although the nature of the dysbiosis, and how this 
relates to patient genotype, remains to be clearly defined. Of 
interest, a number of groups have recently demonstrated increased 
numbers of mucosal adherent-invasive E. coli (AIEC) in patients 
with IBD. Strains of AIEC isolated from CD patients with ileal 
disease induce epithelial injury and subsequent inflammation. In 
addition, elegant studies from Garrett et al. have demonstrated 
that enteric microflora grown in a strain of immunodeficient 
mice (Tbet and Rag1 null) may transmit colitis to wild-type mice 
through as-yet undefined microbes.17
Studies have implicated diminished levels of Faecalibacterium 
prausnitzii as being associated with a higher risk of postopera-
tive recurrence of ileal CD. Collectively, these studies underscore 
the relevance of the host-microbial interaction in IBD and the 
importance of achieving better definitions of these processes to 
reach and understanding of the pathophysiology of these disor-
ders. Despite the abundance of sensing and effector mechanisms 
that are available to trigger inflammatory immune responses to 
microbial intruders, the usual response to indigenous gut bacteria 
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mediating robust early immune control of intracellular bacterial 
pathogens.30 Riol-Blanco and co-workers demonstrated that the 
IL-23 receptor is vital for the maintenance of CD4-, CD8- T cells 
as well as γδ T cell populations, which provide early adaptive 
immune responses to infection. These IL-17 producing effector 
T cells are crucial for protection of mice against both L. monocy-
togenes and Francisella tularensis challenge. This extends the role 
of IL-23 to protection against intracellular pathogens, as well as 
differentiating inflammatory, auto-immune predisposing CD4+ 
major histocompatibility complex (MHC) class II-restricted 
Th17 cells, from their protective γδ or double-negative T cell 
counterparts. This, along with the role of Th17 cells in organ-
specific inflammation, raises the hope that therapeutic disruption 
of the IL-23 pathway will control auto-immune inflammation 
without impairing systemic immunity.
Autophagy genes ATG16L1 and IRGM are specifically asso-
ciated with CD. Association between the ATG16L1 (autophagy-
related 16-like 1) gene on 2q37.1 and CD was by identified by a 
GWA study, as well as by an independent study of ~7,000 non-
synonymous SNPs.31 Both of these studies identified one amino 
acid changing polymorphism (T300A, Ala197Thr, rs2241880) 
within the ATG16L1 gene that was highly associated with CD, 
a finding replicated in the index report and subsequently widely 
elsewhere.26,32 Based on haplotype and regression analysis, this 
variant was found to explain all the signals observed at the 
ATG16L1 locus. It is not, however, associated with UC.25
Although the detailed functional impact of the Ala197Thr 
variant remains unclear, it affects a highly conserved motif imme-
diately adjacent to the part of the gene encoding the WD repeat 
domain. Atg16L1 itself is known to play a key role in mammalian 
autophagy,32 a process recognized as playing a role in both innate 
and adaptive immunity. The Atg16L1 protein is widely expressed 
not only in intestinal epithelial cells, but also in lymphocytes and 
macrophages. Atg16L1 appears to play multiple roles related to 
innate immunity, particularly in relationship to Nod proteins. 
Both Nod1 and Nod2 were recently shown to direct Atg16L1 
to bacterial entry sites on the plasma membrane, thus initiating 
autophagy to remove invading pathogens.20 Initially, the authors 
demonstrated that Nod agonists induce autophagy in human 
and mouse cells. In mice, exposure to Nod1 or Nod2 ligands via 
intraperitoneal injection following thioglycholate priming shows 
Nod-dependent induction of autophagy within isolated macro-
phages. However, rapamycin or lipopolysaccharide (LPS) induc-
tion of autophagy is normal in cells isolated from either Nod1- or 
Nod2-deficient animals. Using Shigella flexneri and Listeria 
monocytogenes infection of mouse embryonic fibroblasts (wild 
type or Nod1-deficient) Travassos and co-workers demonstrated 
that autophagic control of both Shigella and Listeria infection 
is dependent upon Nod1, but independent of RIP2 and NFκB.
The Nod proteins both immunoprecipitated with Atg16L1, 
and a fraction of these proteins also co-located at the plasma 
membrane when overexpressed, in a RIP2-independent manner. 
Both endogenous and overexpressed Nod2 and AtgG16L1 (and 
overexpressed Nod1) are observed to co-locate preferentially at 
sites of bacterial entry following short periods of infection with 
S. flexneri. However, the Nod2 association with Atg16L1 is 
pathways and that these might drive a physiologically “inappro-
priate” inflammatory response, but this has yet to be proven.
Recent years have seen a revolution in the ability of investiga-
tors to identify the genetic determinants of IBD and indeed all 
complex diseases. Progress has been made possible by endeavors 
such as the human genome project and advances in genotyping 
technologies that make hypothesis-free methods of testing the 
majority of the human genome for association with disease a trac-
table proposition. Such genome-wide association (GWA) studies 
test hundreds of thousands of markers, known as single nucleo-
tide polymorphisms (SNPs) in thousands of individuals, seek-
ing markers at which there are statistically significant differences 
in allele frequency between cases and controls. GWA studies are 
being used across the spectrum of complex disease, but nowhere 
has their application been more successful than in the field of 
CD genetics.
Since late 2006, three high-density GWA studies and one 
non-synonymous SNP scan have reported a total of 11 CD sus-
ceptibility loci, adding to NOD2 and OCTN/IBD5, previously 
identified by fine mapping within linkage intervals. A subsequent 
meta-analysis of GWA studies reported in 2008 brought to >30 
the number of confirmed susceptibility loci for CD. These loci 
have now been studied in large UC cohorts, which identified sev-
eral loci that are shared between UC and CD, but also a number 
of loci that are disease-specific.
Results from GWA Studies in IBD
The Th17 pathway is associated with CD and UC. In the 
first reported GWA study of CD, variants in the interleukin 23 
receptor gene (IL-23R) on chromosome 1p31 were found to be 
unequivocally associated with CD susceptibility.21 The finding 
was rapidly replicated and extended to confirming association 
with UC.21,22 Perhaps surprisingly, a rare variant (Arg381Gln) in 
the IL-23R gene was shown to confer protection against develop-
ing IBD, with multiple other IL-23R variants showing indepen-
dent association. As with NOD2, association of IL-23R was not 
seen in a well-powered CD association study from Japan.23
The importance of the IL-23 pathway has been further high-
lighted by the finding of association between variants in IL-12B, 
which encodes the p40 subunit shared between IL-12 and IL-23, 
and both CD and UC susceptibility.24-26 Most recently, the CD 
meta-analysis highlighted a number of other components of the 
Th17 pathway which are also associated with CD, including the 
signal transducers STAT2 and JAK3, the chemokine receptor 
CCR6 and co-stimulatory molecule ICOS-L27 (Table 1). STAT2 
and JAK3 are also associated with UC.28
The IL-23/IL-12 pathway has become the subject of inten-
sive study in the field of immunology as it plays a key role in 
determining differentiation of naïve T cells into effector Th1 
cells (driven by IL-12) or Th17 cells (driven by IL-23). Begum 
et al.29 reported that specific bacterial components such as pep-
tidoglycan can differentially induce antigen presenting cells 
to produce IL-23 rather than IL-12, with this early regulatory 
mechanism potentially leading to distinct patterns of inflamma-
tory response. A recent paper has highlighted the role of IL23 in 
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Atg16L1 variants are studied, notably failure to induce autophagy 
in response to MDP in the presence of either CD-predisposing 
gene variant. In DCs this led to a failure to translocate bacte-
ria to lysosomes, resulting in reduced bacterial killing. DCs in 
which Atg5, 7 or 16L1 have been ablated via siRNA also failed to 
relocate MHC class II to the cell surface following MDP stimu-
lation. This is associated with loss of the localization of MHC 
class II to autophagic compartments. In DCs from CD patients 
with either CD-associated Nod2 or ATG16L1 variants, a similar 
loss of MHC class II localization with the autophagic compart-
ment is observed. Functionally, this results in curtailed antigen 
presentation and an inability to generate CD4+ T cell responses 
to bacterially-derived antigens following infection. These studies 
demonstrate direct links between NOD2 frameshift variants and 
autophagic bacterial control, as well as a novel Nod/autophagic 
signaling axis. It will be of interest to see if, as well as colocal-
ization of Atg16L1 and Nod proteins at the plasma membrane, 
fully-formed autophagsomes provide a platform for Nod and 
other pathogen-associated molecular pattern (PAMP)-mediated 
signaling, via the delivery of recognition/ATG complexes to sites 
inhibited by the known CD-associated NOD2 frameshift muta-
tion, resulting in impaired autophagy of invading S. flexneri and 
reduced cytokine secretion in bone-marrow-derived macrophages 
from transgenic mice expressing the CD-associated truncation. 
In addition, the authors show that human cells homozygous for 
the CD-associated ATG16L1 polymorphism (Ala197Thr) show 
an impaired autophagic induction upon treatment with peptido-
glycan or MDP (the Nod1 and 2 ligands, respectively), suggest-
ing that Nod2 and Atg16L1 localization to the plasma membrane 
is required for optimal innate immune signaling.
A related study sheds further light upon autophagy and the 
role of ATG16L1 variants in stimulating innate immunity, and 
thus driving adaptive immune responses to pathogens. Cooney 
et al. demonstrated that both functional Nod2 and Atg16L1 are 
required in dendritic cells (DCs) for the induction of autophagy 
in response to Nod2 stimulation and proper induction of the 
antigen-presentation and bacterial handling pathways.19 Unlike 
in the epithelial and lymphoblastoid cells used by Travassos et 
al. these effects in DCs are RIP2 dependent. However, the DC 
system shows similar defects when CD-associated Nod2 and 
Table 1. Selected other IBD-associated loci
Locus Proposed gene Pathway Other evidence
Cluster of SNPs 5.5 kb 
upstream of PTPN2
PTPN2; T cell protein tyrosine 
phosphatase (TCPTP)
Negative regulator of inflammatory  
JAK-STAT signaling
Mouse knockouts show elevated IFNγ, 
TNFα and IL-12243
ICOSLG
Inducible T-cell co-stimulator 
ligand
Co-stimulatory molecule on antigen  
presenting cells, key role in Th17 cells from 
naïve CD4 lymphocytes27
STAT327
Signal transducer and  
activator of transcription 3
Signal transduction in many cytokine  
pathways including IL23 and IL6 and their 
stimulation of Th17 cells244
JAK228 Janus kinase 2
One of the crucial kinases in the STAT3 
pathway
CCR627
Chemokine (C-C motif)  
receptor 6
G protein-coupled receptor expressed in 
immature DCs and memory T cells,  
mediates tissue-specific migration during 
epithelial inflammation245
Recently shown to be expressed by Th17 
cells in CD118
TNFSF1527,246
Tumor necrosis factor  
superfamily, member 15
Induces NFκB activation, potentiates IL-2 
signaling and secretion of IFNγ by  
T lymphocytes.
Strongly associated with CD in Japan, more 
modestly so in European populations; 
known to be upregulated in CD247
NKX2-324-26
NK2 transcription factor 
related, locus 3
Poorly characterized transcription factor 
expressed in the intestine
Variants associated with CD and UC, the 
former in Japanese as well as Europeans
Gene desert on chro-
mosome 5p13
PTGER424,26,248
SNPs at 5p13 correlate with PTPGER4 
expression
Encodes prostaglandin receptor EP4, 
strongly implicated in mouse model of 
IBD249
MST125,26,250 Macrophage stimulating 1
MST1 induces phagocytosis by resident 
peritoneal macrophages
Variants associated with both UC and CD
ITLN127 Intelectin 1
ITLN1 recognizes galactofuranosyl residues 
found in cell walls of various  
microorganisms but not in mammals
Expressed in intestine, including in Paneth 
cells, suggesting a role in innate  
immunity251
ECM125 Extracellular matrix protein 1
Associated with UC in UK-based study, likely 
due to altered intestinal permeability25
IL-10252,253 Interleukin 10 Variants associated with UC
IL-10 knock-out mice widely used as models 
of IBD, colitis depends upon gut flora
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induced. Interestingly, orangutans and gibbons possess both 
functional and non-functional IRGM alleles. It seems that the 
locus is continuing to evolve in humans, possibly reflecting our 
ever-changing relationship with intracellular pathogens.
The emerging evidence would suggest that dysregulation of 
autophagy genes may contribute to the pathogenesis of inflam-
matory bowel disease via several routes: through Atg5 mediated 
removal of autoreactive CD4+ T cells; through Atg16L1-mediated 
endotoxin-induced inflammatory signaling in macrophages and 
Paneth cells, and potentially via autophagy related lymphocyte 
homeostasis. Each of these will be further explored in subsequent 
sections of this review. Much remains to be done to elucidate the 
precise mechanisms of ATG16L1 and IRGM polymorphisms in 
the pathogenesis of Crohn disease, but autophagy appears to be 
paramount to the mucosal immune system.
GWA studies have thus yielded many important insights 
into IBD pathogenic mechanisms, particularly relating to the 
roles of the Th17 pathway and innate immunity (particularly 
autophagy), but a number of surprises and challenges have also 
revealed themselves. It is evident that nearly all of the susceptibil-
ity loci identified individually confers only a modest increase risk 
and that, despite having identified >30 CD susceptibility genes, 
only ~20% of the genetic variance has yet been accounted for. 
Characterizing the remainder is one of the major future goals for 
IBD geneticists.
In addition, for the majority of loci the associated SNPs are 
simply markers and the true causal variant(s) have yet to be 
identified. The methodologies for such fine-mapping have yet 
to be fully worked out. Further hindering functional studies is 
that the cellular targets for a given IBD-predisposing variant 
are still unclear for most genes. A further confounding factor 
is that many causal variants appear to be non-coding,27 most 
likely predisposing to IBD as a consequence of their impact on 
the regulation of gene transcription. Indeed, nearly a third of 
the confirmed loci lie in so-called “gene-deserts”. Determining 
exactly how each of these affect transcriptional regulation will 
challenge biologists beyond the IBD community, and may have 
far-reaching implications for our understanding of genetics in a 
broader sense.
Autophagy and the Role of Atg16L1— 
From Yeast to Mammals
Autophagy was first identified as a starvation response in yeast, 
and the yeast system remains the best studied and characterized, 
despite considerable recent efforts in other models. It has been 
assumed that yeast represents the ancestral system, with mam-
malian autophagy exhibiting increased complexity and regula-
tion. Molecular and genetic evidence suggest that the role of 
autophagy in multicellular organisms extends beyond starvation 
responses and has an impact upon other stress-induced pathways, 
as well as playing tissue-specific roles in the immune response. 
However, the core functions and apparatus remain conserved 
from yeast, forming a bulk degradation system, which maintains 
cellular homeostasis. In concert with the proteasome, autophagy 
degrades and recycles cellular components, reducing cellular 
of autophagocytosed bacteria or by engulfing pathogen-derived 
ligands and thus enhancing or turning off signaling.
Further emphasizing the importance of autophagy in CD 
pathogenesis, the Wellcome Trust Case Control Consortium 
(WTCCC) identified association between variants in another 
key autophagy gene, immunity-related guanosine triphosphatase 
(IRGM) and CD susceptibility. A panel of 2,000 CD cases and 
3,000 controls was used in the index GWA scan, with replication 
in an independent panel.24,33 Resequencing did not identify any 
coding variants in IRGM, but subsequent work has shown the 
associated variants to be in tight linkage disequilibrium with a 
copy number variant 5' of IRGM and has demonstrated impact 
on both gene expression and adverse impact on handling of intra-
cellular bacteria.34
IRGM. In mice the interferon-induced Irg family contains 
20 proteins, many of which are necessary for IFNγ mediated 
resistance to intracellular pathogens.35-38 Two IRG orthologues 
are found in humans, the widely expressed IRGM gene and the 
testis-restricted IRGC gene. IRGM has a role in the autophagy-
mediated destruction of Mycobacterium bovis BCG and Salmonella 
typhimurium, in an expression dependent manner.34,36-38 In the 
M. bovis BCG model of tuberculosis, IRGM-dependent clearance 
of bacteria in macrophages is associated with IRGM localization 
to bacteria-containing compartments. This feature is common to 
both human IRGM and mouse IRGM1.36,37 Autophagy targeted 
BCG vacuoles acquire lysosomal markers and the vacuole is acid-
ified, suggesting fusion with the lysosome effects anti-bacterial 
control.
Single nucleotide polymorphisms (SNPs) close to IRGM have 
been strongly correlated with Crohn disease (CD) susceptibil-
ity in genome wide association studies (GWAS).24,32 A large 20 
Kb deletion of potential regulatory sequence is in perfect link-
age with the functional polymorphisms associated with CD.34 
The regulation of IRGM in humans is complex. Different tis-
sues and cell lines heterozygous for the two haplotypes (CD risk 
and CD protective) express varying levels from each allele. In a 
cell culture model of S. typhimurium infection decreased IRGM 
expression significantly inhibits the efficiency of anti-bacterial 
autophagy.34 It is possible that IRGM is regulated in a cell-type 
specific manner and that altered expression induced by the CD 
risk deletion may result in cell specific phenotypes.
The evolution of the IRG gene family also appears to have 
been complex. A number of non-human primates, through 
duplication and diversification events, have evolved up to 21 
interferon-regulated genes. Sequenced prosimian lemur species 
(Lemur catta and Microcebus murinus) have three IRG genes 
clustered in a phylogenetically similar manner to mice. Through 
study of Old World and New World monkeys, it appears that ~40 
million years ago, IRGM became non-functional in a common 
ancestor of these species and was resurrected ~20 million years 
later in the common ancestor of humans and African great apes.39 
The original loss of the gene is attributed to the integration of 
an Alu repeat disrupting the ORF. The restoration of the ORF 
coincides with the integration of an ERV9 element. Said element 
serves as a functional promoter for the human IRGM gene, sug-
gesting that alterations of the gene expression are retroposon 
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Atg8, is conjugated to the head group of 
phosphatidylethanolamine (PE) through 
an amide bond, which is mediated by 
Atg4 (a C-terminal processing enzyme), 
Atg7 and Atg3 (E2-like enzyme).45,46
These two conjugation systems are 
highly conserved in eukaryotes.47,48 In 
mammals, Atg8 homologs consist of three 
distinct families: the LC3, GABARAP 
and GATE-16 families. All of them can 
be conjugated to PE and localized on auto-
phagosome membranes.49,50 The Atg12 
system is also conserved. Atg12 is conju-
gated to Lys130 of Atg5 in mammals.51 
The mammalian Atg12–Atg5 conjugate is 
multimerized by Atg16L1 (a mammalian 
Atg16 homolog) to form a large complex, 
which is estimated to be 800 kDa based 
on gel filtration experiments.47 It should 
be noted that the structures of yeast Atg16 
and Atg16L1 are quite different. Atg16L1 
of various higher eukaryotes includ-
ing mammals has a large C-terminal 
WD repeat domain in addition to the 
N-terminal Atg16-like region (Fig. 1B). 
Since the WD repeat domain is involved 
in protein-protein interactions, there may 
be an unidentified factor(s) interacting 
with Atg16L1 through this domain. This 
WD domain may be important for regu-
lation or specific subtypes of autophagy, 
perhaps in response to pathogen infection.52 Mice deficient in 
Atg3, 5, 7 and 16L die within one day after birth,53-56 apparently 
unable to transition from placental to intermittent oral nutrition. 
Autophagosome formation is defective in cells derived from these 
knockout mice, suggesting that these two conjugation systems 
are essential for autophagy in mammals.
An in vitro reconstitution experiment revealed that the 
yeast Atg12–Atg5 conjugate interacts with Atg3 and facilitates 
Atg8–PE conjugation.57 Atg8–PE and LC3–PE conjugation 
are also severely affected in vivo both in yeast and mammalian 
cells defective in the Atg12 conjugation system.55,58,59 Thus, the 
Atg12–Atg5 conjugate behaves as if it is an E3-like enzyme in the 
Atg8/LC3 conjugation system. In contrast, Atg16 is not essen-
tial for Atg8–PE formation, at least in yeast,59 and therefore, the 
Atg12–Atg5-Atg16 complex must have some function other than 
simple catalysis of the Atg8–PE conjugation. One possible func-
tion is recruitment of Atg8 to the phagophore to form Atg8–PE. 
If Atg12–Atg5-Atg16L1 is artificially expressed on the plasma 
membrane in mammalian cells, LC3 can be lipidated on this 
membrane.60 Another interesting observation is that Atg16L1 
can interact with Rab33B in a GTP-dependent manner and this 
interaction is important to promote autophagy.61 Rab33B is a 
Golgi-resident protein, but is partially redistributed to the phago-
phore under starvation conditions. Thus, Rab33B may regulate 
autophagy through interaction with Atg16L1.
stress and maintaining an amino acid pool essential for survival 
during periods of starvation.3-5 Autophagy operates through the 
encapsulation of organelles and cytoplasm within a membrane-
bound organelle, termed the autophagosome. The apparatus 
used to create this unique structure is outlined below.
Yeast genetic analyses have thus far identified 34 autophagy-
related (ATG) genes.40,41 Among these genes, ATG1-10, 12–14, 
16–18, 29 and 31 are required for autophagosome forma-
tion.41,42 These gene products are classified into five functional 
groups: (1) the Atg1 protein kinase complex, (2) the Atg14-
phosphatidylinositol 3-kinase complex, (3) the Atg2-Atg18-Atg9 
complex, (4) the Atg12 conjugation system and (5) the Atg8 con-
jugation system.41
Both the Atg12 and Atg8 conjugation systems are ubiquitin-
like systems, which are thought to be involved in the elongation 
step of the phagophore membrane (Fig. 1A). Atg12, a ubiquitin-
like protein, is conjugated to Lys149 of Atg5 through an isopep-
tide bond.43 This conjugation reaction is mediated by Atg7 (an 
E1-like enzyme) and Atg10 (an E2-like enzyme). The resulting 
Atg12–Atg5 conjugate (en dash is used to denote a covalent link-
age) is multimerized by Atg16.44 Atg16 is a 150-amino acid pro-
tein that contains an Atg5-interacting domain and a coiled-coil 
domain at its N and C terminus, respectively (Fig. 1B). Atg16 
forms a dimer through the coiled-coil domain, thereby cross-link-
ing the Atg12–Atg5 conjugates. Another ubiquitin-like protein, 
Figure 1. Biochemical features of Atg16L1 and its related proteins. (A) The Atg8/LC3 and Atg12 
conjugation systems. In the Atg8/LC3 conjugation system, the C-terminal arginine (this C-terminal 
extension is much longer in human and mouse) is first cleaved off by Atg4 to expose the glycine 
residue. Atg8/LC3 is then activated by Atg7, transferred to Atg3 and finally conjugated with PE. 
Atg8/LC3–PE is deconjugated again by Atg4. In the Atg12 system, Atg12 is activated by Atg7, trans-
ferred to Atg10 and then conjugated to Atg5. Atg12–Atg5 is multimerized by Atg16(L). (B) Yeast 
Atg16 and human Atg16L1 structures. The coiled-coil domain and C-terminal WD repeat domains 
are shown. Binding sites of interacting partners are also indicated.
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has been suggested to be involved in the regulation of inflam-
mation,31,32,72-74 yet the mechanisms underlying the suppression 
of inflammatory responses by autophagy are poorly understood.
Recently, the Akira laboratory generated ATG16L1-deficient 
mice and demonstrated that Atg16L1 is essential for autophago-
some formation, with most knockout mice dying within a day of 
birth.55 Therefore studies have utilized Atg16L1-deficient murine 
embryonic fibroblasts and macrophages, as well as chimeras lack-
ing ATG16L1 expression in specific cell lineages to elucidate the 
role of Atg16L1 and autophagy in innate immune responses.
Enhanced endotoxin-induced IL-1β production by Atg16L1-
Deficient macrophages. Toll-like receptors (TLRs) are a family 
of pattern recognition receptors that target microbial compo-
nents and play a critical role in the innate immune response.75 
Aberrant activation of TLR signaling pathways, often induced by 
disruption of the negative regulatory machinery, results in mas-
sive inflammation and may cause septic shock or autoimmune 
disease.70,75 Therefore, Saitoh et al. attempted to identify the role 
of Atg16L1 in TLR-mediated innate immune responses, particu-
larly the LPS-induced production of inflammatory cytokines, 
such as TNFα, IL-6 and IL-1β.55 Although the involvement 
of autophagy-related proteins in the TLR-mediated antiviral 
response and in phagocytosis has been reported, it is unclear 
whether Atg16L1 regulates the production of inflammatory cyto-
kines induced by TLR engagement.76,77 Although the production 
of TNFα and IL-6 was almost normal in Atg16L1-deficient 
macrophages, IL-1β production was enhanced compared with 
that in wild-type macrophages (Fig. 2A).55 Synthetic lipid A, an 
active component of LPS, also potently induced IL-1β produc-
tion in Atg16L1-deficient cells. In addition, non-invasive Gram-
negative bacteria, such as Enterobacter aerogenes, Escherichia 
coli and Klebsiella pneumoniae (all found in the commensal 
flora), potently induced IL-1β production by Atg16L1 deficient 
macrophages.55
Basal autophagy, but not stimulation-induced autophagy, 
regulates IL-1β production. An important question is whether 
enhanced IL-1β production results from Atg16L1 deficiency per 
se or autophagy deficiency in general. To address this Saitoh 
et al. used mutant mice deficient in Atg7, another essential 
autophagy protein.53 Like Atg16L1-deficient macrophages, Atg7 
deficient macrophages show increased production of IL-1β, sug-
gesting that the disruption of autophagy is responsible for the 
phenotype.
There is increasing evidence that basal autophagy plays an 
important role under pathophysiological conditions like the 
immune response, neurodegeneration and hepatic dysfunc-
tion.76,78-80 Recently, the potential involvement of TLR signal-
ing in the induction of autophagy has been reported.81,82 In 
contrast to previous reports, LPS stimulation does not increase 
the number of endogenous LC3 puncta in mouse primary mac-
rophages.55 However, infection with Salmonella typhimurium, 
an invasive Gram-negative bacterium, results in Atg16L1-
dependent formation of bacteria-containing autophagosomes 
in macrophages.55 The formation of these autophagosomes does 
not require engagement of TLRs, since it occurrs in the absence 
of both MyD88 and TRIF, both essential adaptor molecules for 
The physiological role of Atg8/LC3 also remains incompletely 
understood. It has been demonstrated that Atg8–PE can be oligo-
merized and induces membrane hemifusion in vitro.62 Although 
this function could be physiologically relevant, it is unknown 
whether autophagosome formation indeed requires membrane 
hemifusion. Another yeast study demonstrates that the Atg8 
expression level regulates the size of autophagosomes.63 Although 
its mechanism is unknown, it may be related to a recent find-
ing that human Atg3 interacts with FNBP1L, a human ortholog 
of yeast Bzz1.64 FNBP1L and Bzz1 contain an F-BAR domain, 
which is involved in generating membrane curvature generation. 
FNBP1L is dispensable for canonical autophagy, but is essential 
for autophagy of intracellular Salmonella. Besides the proposed 
role of Atg8/LC3 in membrane elongation, it may also be impor-
tant for completion of autophagosome formation. Unclosed auto-
phagosomes accumulate in Atg3-deficient fibroblasts56 and cells 
expressing a dominant negative Atg4B (Atg4BC74A).65 These phe-
notypes may be interpreted as the result of inappropriate elonga-
tion of the phagophore membrane. Overall, Atg12–Atg5-Atg16L 
and Atg8/LC3–PE are important for proper elongation and pos-
sibly for completion of the phagophore membrane.
APG15 is identical to APG16. The term ATG is a unified 
name of several autophagy-related gene collections such as APG, 
AUT, CVT, GSA, PAZ and PDD.66 The initial screen for autoph-
agy defective mutants performed by Y. Ohsumi’s group isolated 
15 apg mutants (apg1-apg15).67 Later, apg7 and apg11 were deter-
mined to be allelic.68 In 1999, another novel APG gene was iden-
tified by a yeast two-hybrid screen using Apg12 as bait.44 At that 
time, APG2 and APG15 had not yet been cloned. When a yeast 
strain deficient for this novel gene was mated with either mutant 
apg2-1 or apg15-1, autophagy deficiency was restored. This 
complementation test indicated that this novel gene was neither 
APG2 nor APG15 and it was named APG16.44 However, cloning 
of the APG15 gene revealed that it was identical to APG16 and 
apg15-1 was a nonsense (UGA) mutation of the 83rd CGA codon 
(arginine) of APG16.69 This result was very surprising because 
a diploid strain generated by mating of apg15-1 and apg16Δ 
strains showed normal autophagic activity.44 Further detailed 
analysis revealed that this discrepancy was due to the strain back-
ground used in the mating experiment. A [PSI+]-like cytoplasmic 
omnipotent suppressor was present in the apg16Δ strain, which 
decreased translational fidelity and caused misreading of the 
nonsense mutation in the apg15-1 allele.69 As a result, the pheno-
type of the apg15-1 allele was partially suppressed. Although the 
precise nature of this cytoplasmic suppressor remains unknown, 
it seems to be widely distributed in laboratory yeast strains, but 
not in the one used in the apg mutant screening. Therefore, the 
original apg15-1 mutant shows a complete autophagy-defective 
phenotype. Now, ATG11 and ATG15 are the gene names assigned 
to the previously named CVT9/GSA9/PAZ6/PDD18 and AUT5/
CVT17 genes, respectively.
The Impact of Autophagy upon Inflammation
In mammals, systems for protein degradation are critical for tight 
control of the inflammatory immune response.70,71 Autophagy 
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Among the TLR family members, TLR2, TLR4 and TLR5 
detect bacterial components and are required for the antibacte-
rial immune response.75 The Akira group found that the ligand 
for TLR4, but not the ligands for TLR2 or TLR5, induced IL-1β 
production by Atg16L1 deficient macrophages.8 These findings 
prompted them to assess the involvement of TRIF signaling, 
which is selectively initiated by the engagement of TLR4 on 
macrophages.75 They generated Atg16L1-TRIF double-deficient 
mice and found that Atg16L1-TRIF double-deficient macro-
phages failed to produce IL-1β in response to LPS stimulation 
because of a lack of caspase-1 activation (Fig. 2A).55 The addition 
of IFNβ or IFNγ enhances TLR2-mediated IL-1β production 
by Atg16L1 deficient macrophages.8 These results indicate that 
disruption of Atg16L1 in macrophages causes enhanced LPS-
induced IL-1β production in a TRIF-IFN-dependent manner.
Elevated levels of reactive oxygen species in Atg16L1-
deficient macrophages. Recent studies have shown that ROS 
play an important role in the activation of caspase-1 induced by 
ATP, uric acid crystals, silicas and asbestos.83,84 Therefore, the 
potential involvement of ROS in the enhanced IL-1β produc-
tion by Atg16L1-deficient macrophages was assessed. Strikingly, 
TLR signaling pathways.55,75 The failure of autophagy induction 
by TLR signaling suggests that inhibition of basal autophagy 
induces IL-1β overproduction by the macrophages stimulated 
with endotoxin.
Enhanced TRIF-dependent caspase-1 activation by dis-
ruption of Atg16L1. Another question concerns the molecular 
mechanism underlying enhanced endotoxin-induced IL-1β pro-
duction in Atg16L1-deficient macrophages. The expression of 
both IL-1β mRNA and immature pro-IL-1β protein following 
LPS stimulation of Atg16L1 deficient macrophages was almost 
comparable with that seen in wild-type cells, indicating an abnor-
mality in post-translational regulation.55 In Atg16L1-deficient 
macrophages, LPS stimulation induces the cleavage of caspase-1 
to an activated form, which mediates the processing of pro-IL-1β 
to mature IL-1β (Fig. 2A).83,84 IL-18 production, which is medi-
ated by caspase-1, is also enhanced in Atg16L1-deficient macro-
phages stimulated with LPS. The activation of NFκB and p38 
signaling pathways by LPS is similar in wild-type and Atg16L1-
deficient macrophages, suggesting that the enhanced IL-1β pro-
duction in Atg16 deficient cells is not due to disruption of these 
signaling pathways.55
Figure 2. Autophagy suppresses endotoxin-induced inflammatory immune responses. (A) TLR4 triggers both MyD88- and TRIF-dependent signaling 
pathways in response to LPS. The IKKα-IKKβ-NEMO complex mediates the activation of the transcription factor NFκB which, in turn, induces transcrip-
tion of pro-inflammatory cytokines, such as TNFα, IL-6 and pro-IL-1β. The TBK1-IKK-i complex mediates the activation of the transcription factor IRF-3, 
which then induces the transcription of Type I IFN and IFN-inducible genes. In autophagy-deficient cells, high levels of ROS are generated and mediate 
TRIF-dependent caspase-1 activation resulting in the production of IL-1β. However, in wild-type macrophages, limited amounts of IL-1β are induced by 
LPS due to a lack of ROS generation. (B) Hypothetical model of intestinal inflammation caused by autophagy deficiency. The intestinal epithelial layer 
lacking autophagy seems to be susceptible to microbial infection due to the disrupted maturation of Paneth cells. The barrier function of intestinal 
epithelial cells is also compromised by chemical stress such as DSS exposure resulting in the invasion of commensal bacteria. Macrophages and 
dendritic cells detect invading bacteria and produce inflammatory cytokines. Autophagy-deficient macrophages produce high levels of IL-1β and IL-18 
leading to severe inflammation mediated by lymphocytes.
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that autophagy is required for the maintenance of mitochondrial 
homeostasis and that targeted disruption of the autophagy-related 
genes results in the accumulation of ROS in immune cells.87,88 S. 
Akira and colleagues are currently investigating whether mito-
chondrial ROS are involved in IL-1β production by Atg16L1-
deficient macrophages.
The Nod-like receptor (NLR) family members, IPAF and 
NALP3 have been well studied; they each form a complex called 
an inflammasome with an adaptor molecule, ASC, which acti-
vates caspase-1, resulting in the production of IL-1β.83,84 The 
IPAF inflammasome, which detects the protein flagellin on S. 
typhimurium, mediates both IL-1β production and caspase-1-in-
duced cell death and is essential for host defense. The NALP3 
inflammasome detects a variety of stimulatory molecules such 
as ATP, uric acid crystals, silica and asbestos, and plays a major 
role in the induction of inflammation by regulating caspase-1 
activation.83,84 LPS-primed Atg16L1-deficient macrophages pro-
duce high levels of IL-1β following stimulation by ATP or uric 
acid crystals, both stimulators of the NALP3 inflammasome. 
However, the production of IL-1β induced by S. typhimurium 
mediated by the IPAF inflammasome shows little elevation in 
LPS-primed Atg16L1-deficient macrophages.55 Although cas-
pase-1 activation is critical for LPS-induced IL-1β production by 
autophagy-deficient macrophages, the NLRs responsible for the 
activation of caspase-1 in autophagy-deficient cells have not been 
identified. Therefore, current investigations are concentrating on 
whether activation of the NALP3 inflammasome is required for 
IL-1β production by Atg16L1-deficient macrophages, and also 
whether activation of the NALP3 inflammasome is involved 
in the intestinal inflammation induced by Atg16L1 deficiency. 
The role of NOD2, another NLR implicated in CD, has also 
been examined in ATG16L1-deificient cells. Atg16L1 deficient 
macrophages produced the inflammatory cytokines IL-1β and 
IL-6 in response to MDP, a ligand for Nod2,55 indicating that 
Atg16L1 is not required for Nod2-mediated signaling of cytokine 
production. However, it is still unclear whether the detection of 
invading microbes by Nod2 or other NLRs induces Atg16L1-
dependent autophagosome formation. Further experiments using 
mutant mice lacking NLRs are needed to address this issue.
In conclusion, Atg16L1 regulates the endotoxin-induced 
inflammatory response. Given the importance of the elevated 
expression of IL-1β and IL-18 caused by Atg16L1 deficiency in 
the pathogenesis of mouse model of colitis, it would be of interest 
to assess the role of both autophagy and inflammasomes in the 
development of inflammatory bowel disease in humans.
Autophagy and IBD Immunity— 
The Adaptive Immune System
While the link between autophagy and innate immunity is 
being elucidated through recent studies, there remains a sub-
stantial gap in our knowledge of the role of autophagy in the 
adaptive immune system. Key players in linking innate and 
adaptive immune responses are antigen-presenting cells (APCs), 
which are capable of presenting both exogenous (e.g., bacteria) 
and endogenous (self) antigens to T cells for activating adaptive 
the enhanced IL-1β production from Atg16L1-deficient macro-
phages is blocked by the ROS scavengers N-acetyl-L-cysteine and 
FeTPPS (Fig. 2A).55 Also, the level of ROS in LPS-stimulated 
Atg16L1-deficient macrophages is higher than that in Atg16L1-
TRIF double-deficient or wild-type macrophages. These results 
suggest that ROS accumulate in Atg16L1-deficient macrophages 
following LPS stimulation and induce TRIF-dependent produc-
tion of IL-1β.
Severe dextran sulphate sodium-induced colitis in chimeric 
mice lacking Atg16L1 in hematopoietic cells. Elevated expres-
sion of IL-1β and IL-18 is involved in the development of intes-
tinal inflammation,85,86 and recent studies have reported that 
Atg16L1 is a candidate susceptibility gene for Crohn disease.31,32 
This led to the question as to whether Atg16L1 is involved in 
the development of colitis. Atg16L1-deficient chimeric mice do 
not develop spontaneous colitis and that the large intestines of 
newborn Atg16L1-deficient mice are not inflamed. The number 
of bacteria in the feces of wild-type or Atg16L1-deficient chimeric 
mice is similar with no bacteria detectable in the spleens of these 
animals.55
A corollary question was whether Atg16L1 deficiency exacer-
bated inflammation in a dextran sulphate sodium (DSS)-induced 
experimental model of colitis. Strikingly, chimeric mice lacking 
Atg16L1 in hematopoietic cells died following severe weight 
loss after DSS treatment (Fig. 2B).55 Control chimeric mice 
expressing wild-type Atg16L1 in hematopoietic cells survived. 
Intraperitoneal administration of 3-methyladenine, an autophagy 
inhibitor, increases the levels of IL-1β in serum and reduces the 
survival rate of mice treated with DSS. This suggests that auto-
phagy protects mice from intestinal inflammation. Histological 
analysis reveals a more severe inflammation in the distal colons of 
Atg16L1-deficient mice than that seen in control mice with larger 
areas of ulceration and increased infiltration of lymphocytes. The 
levels of the pro-inflammatory cytokines IL-1β and IL-18 are sig-
nificantly elevated in the sera of DSS-treated Atg16L1-deficient 
chimeric mice relative to controls. Mortality and loss of body 
weight after DSS exposure in Atg16L1-deficient chimeric mice 
are reduced by the injection of anti-IL-1β and anti-IL-18 anti-
bodies, thus demonstrating the involvement of excessive produc-
tion of these cytokines in the development of severe colitis.55
Remaining issues. These studies highlight a novel role for 
autophagy in the regulation of the inflammatory immune 
response. Disruption of autophagy causes TRIF-dependent ele-
vation of ROS in LPS-stimulated macrophages.55 Accumulated 
ROS causes inflammasome activation leading to the production 
of the inflammatory cytokines IL-1 and IL-18. The source of this 
ROS has not been identified; however, Tcshopp and colleagues 
have reported that NADPH oxidase-induced ROS generation is 
required for the activation of caspase-1 as well as for the produc-
tion of IL-1β by stimuli such as ATP, uric acid crystals, silica and 
asbestos.84 However, NADPH oxidase seems not to be involved 
in the accumulation of ROS in autophagy-deficient macro-
phages because inhibitors of NADPH oxidase fail to suppress 
LPS-induced IL-1β production by these cells (Tatsuya Saitoh 
and Shizuo Akira unpublished data). Other possible sources of 
ROS include mitochondria. Recent studies clearly demonstrate 
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can process cytoplasmic influenza and measles virus proteins for 
presentation by MHC class II.99,100 This requires lysosome acidi-
fication, but does not require TAP transporters or protein traf-
ficking through the Golgi apparatus, suggesting direct delivery 
of proteins to lysosomes from the cytosol. This model is consis-
tent with biochemical studies showing that some 35% of peptides 
bound to HLA-DR molecules are derived from nuclear or cyto-
solic proteins101 and that the percentage rises following induction 
of autophagy by starvation. Autophagy also causes downregula-
tion of lysosomal cathepsins and altered patterns of peptide pro-
cessing, suggesting that autophagy has the potential to change 
the nature of peptides presented to CD4+ T cells. Recent studies 
show that autophagosomes labeled with GFP-LC3 fuse directly 
with MHC class II compartments in both epithelial cells and 
professional APCs and that LC3 is delivered constitutively to 
lysosomes over many hours.102,103 Constitutive autophagy is also 
evident in transgenic mice expressing GFP-LC3 where auto-
phagosomes are seen in tissues in the absence of starvation.104 
Autophagy can also deliver model antigens into class II antigen 
processing pathways if they are targeted to autophagosomes by 
fusion to LC3. Presentation of fusion proteins to T cells is lost 
if the lipidation motif in LC3 is mutated to prevent attachment 
to autophagosomes, or following ATG12 silencing.103 Parallel 
studies80 have argued that autophagosome processing of proteins 
for presentation by MHC class II should show a preference for 
long-lived proteins. This proved correct for lymphoblastic cells 
infected with Epstein-Barr virus where the long-lived nuclear 
antigen EBNA1 was presented to CD4+ T cells through a path-
way that was blocked by silencing ATG12. In the same study a 
short-lived EBNA1 lacking the sequences that prevent degrada-
tion by the proteasome was presented by MHC class I rather than 
class II.
The evidence that autophagy delivers cytosolic proteins for 
processing and presentation to CD4+ T cells by MHC class II 
is now very strong. Autophagy may be particularly important 
for intestinal epithelial cells that are not actively endocytic and 
where class II antigen expression increases in an inflammatory 
setting in response to INFγ. Interestingly, INFγ? does not gener-
ate greater numbers of autophagosomes. The increased capacity 
to present antigens in response to INFγ results from increased 
MHC class II expression coupled with increased delivery of LC3 
positive autophagosomes to MHC class II compartments.103 For 
an overview of current concepts in the relationship between 
autophagy and phagocytosis see refs. 105, 106.
In addition to the involvement of autophagy in antigen-presen-
tation that is required for initiating adaptive immune responses, 
autophagy provides significant contributions to immune regu-
lation through its role in proliferation and survival of T cells 
after T cell receptor (TCR) ligation. Double-membrane auto-
phagosomes can form in both human and murine T cells and 
autophagy enhances the survival and proliferation of memory 
T cells through clearance of superfluous mitochondria.87,89,90,107 
Contributions of dysregulated homeostasis of memory T cells 
have been implicated in the pathogenesis of colitis. Indeed, 
implantation of Atg5-deficient thymus induces the development 
of systemic inflammations, including colitis, in the recipient 
immune responses. Autophagy plays a critical role in the MHC 
class II-dependent antigen presentation to CD4+ T cells. Indeed, 
impaired autophagy in a specific APC in the thymus results in 
the development of colitis.89 In addition, autophagy in T cells 
per se is implicated in their survival and proliferation.90 Once 
effector immune responses are generated, regulatory immune 
cells expand to prevent the responding effector cells from caus-
ing harmful effects. Autophagy may directly or indirectly par-
ticipate in the differentiation of several regulatory (T and B) cell 
subsets. Therefore, autophagy is required for the entire immune 
processes involved in the pathogenesis of IBD through control-
ling the function and development of many different cell subsets 
in the intestine.91 In this section, we discuss the potential role of 
autophagy in CD-associated adaptive immune responses.
Antigen sampling by dendritic cells. Bacteria are processed 
by APCs capable of presenting the antigen to T cells. Dendritic 
cells (DCs) are professional APCs that can capture enteric bac-
teria that have invaded the intestinal mucosa by breaching the 
epithelial barrier. They can also sample the bacteria present in the 
intestinal lumen by extending dendrites directly into the lumen 
or by interacting with a specialized epithelial cell termed M cells 
and through neonatal Fc receptor (FcRn)-dependent transport 
of IgG/bacterial antigen complexes across the epithelial layer.92,93 
Intestinal DCs provide a significant contribution to the direct 
linkage between innate and adaptive immune responses. There 
are several DC subsets in the intestine, which play different roles 
in the pathogenesis of IBD.92 Some DC subsets, particularly 
those expressing CD103, maintain tolerance towards commen-
sal enteric microorganisms, whereas others are implicated in the 
generation of effector immune responses against potential patho-
gens.92 A unique DC subset that shares some phenotypic and 
functional features with macrophages increases in the inflamed 
colon of CD patients and in the intestinal granulomas of a mouse 
CD model.94,95 This unique DC subset is able to produce large 
amounts of IL-23 in response to bacterial products. In addi-
tion, local factors present in the intestine, such as thymic stro-
mal lymphopoietin (TSLP) and retinoic acid, further condition 
the function of intestinal DCs.92,94,96 Bacteria-derived adenosine 
5'-triphosphate (ATP) also activates a unique CD70highCD11low 
APC to enhance the differentiation of the Th17 subset.97 
Involvement of autophagy in DC function has become increas-
ingly apparent. Autophagy is required for the recognition of virus 
by plasmacytoid DCs76 and it also enhances the antigen presenta-
tion by DCs facilitating the efficacy of vaccination.98 However, it 
is largely unknown whether autophagy plays a role in the intesti-
nal DC function involved in the pathogenesis of IBD. Therefore 
it is likely that autophagy plays a major role in facilitating and 
controlling antigen presentation and immune activation in the 
gut compartment, in both healthy and diseased states.
Effector immune responses. Cellular degradation systems 
such as proteasomes and lysosomes are used not only for the 
elimination of intracellular bacteria but also influence adaptive 
immune responses. Autophagosomes can engulf cytosolic com-
ponents and thereby deliver cellular and microbial degradation 
products to MHC class II compartments. This was first sus-
pected during experiments in the early 1990s showing that APCs 
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Following bacterial exposure, macrophages from CD patients 
appear to deliver a large proportion of pro-inflammatory cyto-
kines to the lysosomal system, rather than the appropriate secre-
tory pathway.122 This results in reduced bacterial clearance and 
therefore delays in dealing with infectious insults, potentially 
leading to increased ongoing inflammatory responses. This fail-
ure to secrete adequate levels of cytokines is reminiscent of the 
Paneth cell phenotype observed in mouse models and human 
patients with defects in Atg16L1 or other autophagy genes,123,124 
where mucin and cryptidin secretion are compromised. It will be 
crucial to determine whether there are other secretory defects in 
patients with polymorphisms within autophagy genes.
In the tumor microenvironment, high levels of CCL2 and 
IL-6 have been observed to drive production of a tumor-pro-
moting macrophage subset, termed M2.125 This polarization 
occurs as a result of inhibition of apoptosis, via upregulation of 
autophagy and inhibition of caspase activation, in myeloid cells 
recruited to the tumor. Thus, autophagy is involved in profound 
cellular changes in response to cytokines and the impact of defec-
tive autophagy upon cytokine signaling in specific cell types is 
just beginning to be explored.
A major lymphocyte population in the mucosal immune com-
partment is B cells, with over 80% of activated B cells located 
within mucosal tissues.126 As compared to T cells, B cells have 
not typically been considered to be a major source of cytokines. 
However, it is becoming increasingly apparent that, like T cells, 
B cells also produce a wide array of cytokines, particularly under 
inflammatory conditions.127,128 Intestinal inflammatory condi-
tions induce the development of an IL-10-producing regulatory 
B cell subset termed Bregs, which contribute to improving the 
ongoing colitis seen in several IBD models.128 This concept of 
Bregs, which arose from animal models of IBD, is supported by 
recent case reports showing an exacerbation/development of UC 
and a reduction of IL-10 production after B cell depletion therapy 
using humanized mouse anti-human CD20 monoclonal antibody 
(rituximab).129,130 The intestine contains a unique IgM+ B2 B cell 
subset that is characterized by very high expression of MHC class 
II.131 This B cell subset develops in an antigen-independent man-
ner, and significantly expands in the context of inflammation and 
contributes to host defense against enteric microorganisms by 
producing IL-12p70. Peritoneal B1 B cells that produce natural 
IgM against enteric microorganisms have an ability to suppress 
the development of colitis,132 and their homeostasis is known to 
be Atg5 dependent.133 Despite the role of autophagy in MHC 
class II antigen presentation and a known role for Atg5 B cell 
development and homeostasis, the effect of perturbed autophagy 
upon B cell repertoires is still largely unknown.
Intestinal Barrier Function and Oral Tolerance
The epithelium of the small intestine and colon create a com-
plex, dynamic chemical and physical barrier between host and 
microbes, the importance of which is underlined by results from 
recent human genetic studies as well as data from established 
model systems. Ideas that have emerged from such studies in 
model experimental systems are increasingly being translated 
athymic mice, suggesting the requirement of autophagy for the 
appropriate selection of self antigen-specific CD4+ T cells.89
The antigenic responses of CD4+ T cells are determined by the 
diversity of the T cell receptor (TCR) repertoire. In both human 
IBD and experimental models, the TCR repertoire utilized by 
intestinal CD4+ T cells is sharply skewed, suggesting antigen-
specific activation of effector CD4+ T cells.108 Antigens present in 
high-levels in the gut compartment include bacteria-derived fla-
gellins, which have been demonstrated to serve as IBD-associated 
antigens capable of stimulating Th1 and Th17 responses.109
In addition to exogenous antigen presentation, a major func-
tion of autophagy is the regulation of self-responses.110 Autophagy 
contributes to the clearance of apoptotic cells that represent the 
major source of self antigens.111 The role of autophagy in self-
responses recalls past findings in IBD models where the involve-
ment of impaired clearance of apoptotic cells has been proposed 
to exacerbate chronic colitis.112 In addition, commensal bacteria 
are required for exacerbation, but not development, of ileitis in 
the SAMP1/YitFc mice, a model of CD.113 These observations 
raise the possibility that autophagy plays critical roles in the rec-
ognition not only of exogenous antigens, but also for self antigens 
in IBD.
Th1 responses have been implicated in the pathogenesis of 
CD, whereas UC has a significant contribution from Th2 cyto-
kines such as IL-4, IL-5 and IL-13.114 In addition to the Th1/
Th2 theory, recent accumulating studies have unveiled a criti-
cal involvement of the IL-23/Th17 pathway in the pathogenesis 
of IBD.115 IL-12p70 (p40/p35) has generally been believed to be 
a crucial factor involved in the development of CD because of 
the beneficial effect of anti-IL-12p40 treatment on CD patients 
and experimental models.114 However, it is becoming increas-
ingly apparent that IL-23 (a heterodimer of p40 and p19 sub-
units) rather than IL12 (a heterodimer of p40 and p35 subunits) 
contributes to the development of CD.115 Indeed, IL-23 receptor 
polymorphisms are negatively associated with the development of 
IBD.21 IL-23 serves to maintain a Th17 subset that is character-
ized by the production of IL-17 (IL17A), IL-17F, IL-21, IL-22 
and IL-26, but not IFNγ or IL-4.116 An intestine-specific Th17 
subset expressing CD161 has recently been found in humans to 
be significantly increased in the inflamed colon of CD patients.117 
A unique Th17 subset that co-expresses IL-17 and IFNγ has also 
been identified in the inflamed colon, but not in the peripheral 
blood, of CD patients118 and a pathogenic role of IL-17 has been 
demonstrated in some CD models.119,120 These findings highlight 
the significance of Th17 subsets in CD, although it is unclear 
whether autophagy plays a common or distinct role in these func-
tionally different T cell subsets.
However, recent evidence has linked autophagy to the produc-
tion of, and response to, key cytokines, and therefore opened the 
possibility that some of the immune dysregulation observed in 
IBD may result from aberrant autophagic processes. There is also 
evidence that autophagy is affected by the cytokine environment, 
with Th2 cytokines diminishing the ability of macrophages to 
mount an effective anti-tuberculosis autophagic response.121
Recent research has highlighted the finding that cytokine 
secretion is altered in both CD and the tumor microenvironment. 
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cytokines,146-149 and Trefoil factor 3 (TFF3) produced by goblet 
cells in response to TLR2 signaling and a critical downstream fac-
tor of this signaling pathway.150 The lack of production of TFF3 
appears to be a feature of the intestinal mucosa in UC patients 
that carry a polymorphism within TLR2 (R753Q151). Future 
work in both mouse models and human patient material analysis 
should further determine if specific IBD susceptibility alleles can 
affect goblet cell differentiation and/or mucus secretion.
The chemical barrier II: antimicrobial protein-producing 
Paneth cells. Mucus alone is not a sufficient chemical bar-
rier as many members of the intestinal microbiota contain an 
abundance of glycosyl hydrolases,152 thus rendering mucus an 
attractive potential energy source for specific members of the 
microbiota. However, the mucus layer is an important repository 
for immunoglobulins (e.g., IgA) and a variety of antimicrobial 
peptides produced by the intestinal epithelium.
In the small intestine, the primary, but not exclusive, source 
of antimicrobial proteins and peptides is Paneth cells. Their 
main job is to produce, package and export a variety of anti-
microbial proteins/peptides including multiple α-defensins (e.g., 
cryptdins), angiogenin-4, lysozyme and secretory phospholipase 
A2.153,154 These proteins can alter the composition and abun-
dance of individual species of indigenous microbes and appear 
to play a role in the clearance of pathogens. As an example, mice 
engineered to overexpress a human cryptdin were less suscepti-
ble to death when orally infected with high doses of Salmonella 
typhimurium.155 These secretory functions may be directly related 
to IBD since mice with an engineered loss of function for Atg16L1 
contain Paneth cells that do not properly package antimicrobial 
proteins into granules and secrete them into the lumen of the 
intestine.123,124 This defect appears to be the result of the loss of 
autophagy since loss of function of Atg5 and Atg7 in the intesti-
nal epithelium recapitulates the Paneth cell phenotype observed 
in the Atg16L1-deficient mice. In addition, Atg16L1 deficient 
Paneth cells contain a gain of function whereby they express 
increased levels of inflammatory cytokines such as adiponectin 
and leptin. Humans with CD who carry the point mutation in 
ATG16L1 corresponding to one of the susceptibility alleles for 
this disease showed similar loss and gain-of-function defects in 
their Paneth cells as those observed in the mouse model. Mice 
with loss of function of another CD susceptibility gene, the ER 
stress response gene Xbp1, contain Paneth cells that appear to 
undergo premature apoptosis.156 Loss of function of yet another 
CD susceptibility gene, the MDP receptor Nod2 may play a role 
in diminished defensin production in Paneth cells, though this 
result is controversial.157,158 Another link between Paneth cell 
development and CD susceptibility is the presence of polymor-
phisms in the Tcf4 promoter.159 Partial loss of function of this 
gene is related to diminished antimicrobial protein expression.160
Finally, it has been hypothesized that Paneth cells are a source 
of growth factors, and recent data indicates that this role may 
be responsive to the bacterial flora. Some intestinal resident 
microbes such as B. thetaiotaomicron can stimulate Paneth cells 
to produce mRNAs encoding the antimicrobial protein, angio-
genin-4.161 This microbe can also stimulate angiogenesis in the 
mesenchyme of small intestinal villi indirectly through Paneth 
into human IBD utilizing genotyped patient material. From this 
growing body of work, functional disease targets of the mucosal 
barrier have been identified in specific epithelial cell types of the 
gut. This portion of this review will highlight some of the recent 
work in this area and the role autophagy plays in maintaining 
barrier function and oral tolerance.
The chemical barrier I: mucus-producing goblet cells. The 
first line of defense is a layer of mucus that is produced by special-
ized cells within the lining of the epithelium called goblet cells. 
These cells are designed to store mucus for rapid exocytosis. The 
most abundant mucus components, and the main component 
of mucus in the intestine, is the Muc family of glycoproteins;134 
Muc2 being the most common in the colon,135 although the 
expression pattern of related gene products varies with location 
along the proximal to distal intestinal axis.
Mucus is stored in discrete mucin secretory granules (MSGs) 
that typically undergo merocrine secretion, a process by which 
discharge of an individual granule occurs without the loss of any 
part of the apical portion of the cell. This is a rapid process; typi-
cally a single granule is secreted within minutes of the application 
of a given stimulus. A variety of physiological stimuli are known 
to cause MSG secretion (reviewed in ref. 134 and 136) and 
include autonomic nerve stimulation (cholinergic), substance P, 
prostaglandins and ATP/UTP. The latter stimuli bind purinergic 
receptors on the apical surface of goblet cells. These G-coupled 
receptors also regulate fluid secretion (e.g., Cl- ions), and PDGF 
is another known agonist. Neutrophil elastase also has non-recep-
tor-mediated effects on goblet cells to stimulate MSG secretion. 
Since much of our knowledge is based upon lung derived cells, it 
will be important to perform studies on mouse and human gob-
let cells derived from the small intestine and colon to determine 
the unique properties of goblet cells in this organ. A few human 
goblet cell lines that are derived from adenocarcinomas have been 
useful.137 Also, perhaps now the opportunity exists to maintain 
explants or isolated epithelial cells in culture for studies on non-
transformed cells.138,139
The importance of mucin production in the intestine is evi-
denced by studies of mutant mice that lack the main component 
of colonic goblet cell mucus, Muc2.140,141 These mice contain 
decreased lumenal mucus and over time develop spontaneous 
colitis and epithelial tumors. The enhanced susceptibility to 
injury of Muc2 deficient mice can be further evoked either by 
treatment with dextran sodium sulfate or by breeding into an 
IL-10 knockout background.142,143 Interestingly, the loss of func-
tion of other genes such as Mmp9 creates an increased suscepti-
bility to damage by ultimately causing a decrease in Muc2 and, 
thus, mucus production.144 One proposed mechanism by which 
loss of mucus creates inflammation is that the indigenous colonic 
microbes gain direct access to the surface epithelium.145 The 
Muc2 model, while not a known genetic correlate to human CD, 
is an instructive model for the importance of the mucus barrier.
Goblet cells also preferentially express other genes that, when 
knocked-out result in mice with greater susceptibility to gut 
injury. These include: resistin-like-beta (Relmβ), which has been 
proposed to augment mucus secretion from goblet cells in an 
autocrine fashion as well as to stimulate CD4+ T cells to produce 
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activation.171 Loss of function of the three Vav GTPases leads to 
diminished microtubule networks in colonic enterocytes result-
ing in shortened cells. In combination with immune defects in 
the Vav knockout mice, this results in a spontaneous breakdown 
of the colonic intestinal barrier and focal ulceration.
These studies lay the groundwork for potential mechanisms 
by which enterocytes could be defective in IBD. It will be inter-
esting in the future to see how specific susceptibility genes fit into 
these pathways. For example, mice with loss of STAT3 function 
in the intestinal epithelium exhibit worse damage upon dextran 
sodium sulfate treatment and greater numbers of tumors upon 
addition of azoxymethane.172 A key question in moving forward 
is whether these human susceptibility alleles are additive, par-
ticularly with regard to the different aspects of barrier function 
such as chemical, physical, cellular and immune.
Oral tolerance. Oral tolerance has been described in most 
monogastric mammals, including humans.173 A vast range of 
antigens can be used to suppress all aspects of systemic immune 
responses when administered orally, although most of these share 
the property of being inert and/or soluble thymus-dependent 
antigens, such as proteins. Generally, T cell-mediated responses 
and tissue immunopathology are very sensitive to low doses of 
orally administered antigens. By contrast, antibody responses are 
less easily inhibited, and the status of local IgA responses in oral 
tolerance and whether or not they are suppressed as a result of 
orally administerting antigen are still unclear. Despite its pro-
found effects on systemic immunity and its practical and clini-
cal importance, the mechanisms responsible for oral tolerance 
remain elusive.
Mechanisms of oral tolerance. Using very different in vitro or 
in vivo approaches, immune tolerance can occur through active 
suppression, anergy or apoptosis of (self) antigen-reactive lym-
phocytes. However, no clear consensus has been reached about 
the relative importance or contribution of each of these. Indeed 
it is possible that there is a wide range of different regulatory 
mechanisms that may either be important under different cir-
cumstances or that collectively are needed to ensure systemic tol-
erance.174 The question of whether tolerance to the antigens of 
the microbiota exists is unanswered, although some data suggests 
that this is the case. For example, the absence or diminishment of 
antibody responses in animals systemically administered indig-
enous gut bacteria,175,176 differences in immunogenicity of differ-
ent members of the microbiota177 and the finding that normal 
individuals are tolerant to their own microbiota, whereas they 
respond to bacteria of others with a breakdown of tolerance to 
antigens of an individuals own microbiota, resulting in IBD.178
Oral tolerance and intestinal epithelial cells. Intestinal epi-
thelial cells (IECs) possess many of the attributes of professional 
APCs including their ability to sample soluble proteins via non-
selective (fluid-phase pinocytosis) and selective receptor-medi-
ated routes179,180 and express MHC class I and II molecules.181,182 
However, as IECs normally lack expression of the co-stimulatory 
molecules required for full T cell activation,183 they are good can-
didates for tolerogenic antigen presenting cells in vivo. This may 
not, however, be the only mechanism by which IECs can con-
trol and suppress mucosal T cell responses. For example, primary 
cells by an as yet unknown mechanism.162 Paneth cells also pro-
duce inflammatory cytokines in both a constitutive (TNFα163) 
and inducible fashion during injury (e.g., IL-17,164). However, the 
functional significance of Paneth cell cytokine or growth factor 
production has still not been tested experimentally.
Clearly, additional studies of Paneth cell function concerning 
the impact of loss of function (diminished production or delivery 
of antimicrobial proteins) on the intestinal microbiota and gain 
of function (increased inflammatory cytokine production) on 
the mucosal immune system will be critical in the future. Also, 
understanding the triggers of Paneth cell malfunction (if any) in 
a genetically susceptible host will be important aspects of IBD 
pathogenesis.
The cellular barrier: enterocytes. Underlying the mucus 
layer is a physical barrier that is created primarily by absorptive 
enterocytes that dominate the epithelium, lining villi in the small 
intestine and pericryptal cuffs in the colon. The intestinal epithe-
lium is a dynamic barrier in which tightly bound epithelial cells 
are renewed by accelerated division of crypt cells that migrate 
upwards from the bottom of intestinal crypts. It is also a highly 
interactive barrier able to mount rapid responses to pathogens 
through the production of antimicrobial proteins and mobili-
zation of neutrophils and, through collaborations with antigen 
presenting cells, induce mucosal adaptive immune responses.165 
In the small intestine, four differentiated lineages are produced: 
absorptive enterocytes, goblet cells, hormone secreting enteroen-
docrine cells and Paneth cells. All of these lineages except Paneth 
cells migrate out of crypts onto the surfaces of mucosal evagina-
tions into the lumen called villi, migrating to the villus tip over a 
period of 3–5 days. Conversely, Paneth cells migrate to the base of 
crypts where they intermingle with epithelial stem cells and have 
a much longer life span (at least 30 days). The colon contains the 
same basic organization of the epithelium with the two notable 
exceptions that instead of villi, epithelial cells migrate out of each 
crypt onto a flat surface cuff that surrounds each crypt opening 
and there are no Paneth cells. The exception to the latter feature 
is in the proximal portion of the inflamed human colon where 
the presence of Paneth cells is considered to be metaplastic.166
A critical component of the barrier function of the surface 
epithelium is the apical junctional complex that consists of tight 
and adherens junctions; for example overexpression of the myo-
sin light chain kinase in the intestinal epithelium leads to tight 
junction dysfunction and ultimately broad activation of muco-
sal immune responses.167 The function of tight junctions in the 
control of permeability is particularly sensitive to inflammatory 
cytokines such as tumor necrosis factor. Interestingly, specific 
pathogens such as enteropathogenic E. coli disrupt tight junc-
tions to increase permeability.168 This pathogen also targets the 
function of sodium absorption through inhibition of the sodium 
hydrogen exchanger 3.169 Mice with loss of function of this gene 
develop spontaneous colitis,170 suggesting an important immune-
regulatory function for this ion transporter.
Cytoskeletal alterations can also affect the ability of entero-
cytes to create an effective barrier. Loss of function of keratins 
does not appear to cause a defect in handling mechanical stress, 
but instead affects permeability and subsequent Th2 T cell 
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coronaviruses, which induce double-membrane vesicles for use as 
platforms for replication.193-195 There are no examples of intesti-
nal infection by human coronaviruses viruses and the role played 
by autophagy during cornavirus replication has recently become 
controversial.196,197 Picornaviruses such as poliovirus and cox-
sackieviruses do, however, replicate in gastrointestinal epithelial 
cells and induce LC3 processing and translocation of GFP-LC3 
from the cytosol to autophagosomes in cell culture models.198,199 
Poliovirus replicase proteins co-localize with LC3 suggesting that 
replication takes place on autophagosomes, and assembly of the 
replicase complex may be provide the signal that activates auto-
phagy.198 Replicase protein 2BC alone causes conversion of LC3-I 
to LC3-II and recruitment of LC3 to membranes, but co-expres-
sion of poliovirus 3A and 2BC replicase proteins is required to 
convert these membranes into double-membraned vesicles resem-
bling autophagosomes that stain for LC3 and LAMP-1.200,201 
Similarly, infection of IPCs by rotaviruses, which cause viral gas-
troenteritis, results in recruitment of LC3 to virus-induced mem-
branes,202 again providing a link between viral infection of IPCs 
and activation of autophagy. Since our knowledge of the human 
virome is still nascent,203,204 it will be of great interest to observe 
whether specific intestine-tropic viruses are identified as being 
associated with gut inflammation and perhaps inducing chronic 
inflammatory states in susceptible individuals. In a recently pub-
lished study in a mouse model of Atg16L-deficient mice, inves-
tigators found that the persistent infection of a common enteric 
virus in mouse colonies, murine norovirus, is required to trig-
ger abnormal Paneth cell secretion and responses to DSS toxin 
injury. Interestingly, autophagy function is not responsible for 
differences in innate immunity and does not play a role in the 
clearance of the virus. Instead, Atg16L1 function is required 
for the proper function of specific epithelial host cell types in 
response to this persistent infection. Thus, this study is a specific 
virus-plus-susceptibility gene interaction in the context of CD.
Pattern recognition during phagocytosis by antigen-pre-
senting cells. Autophagy can also be activated from outside 
the cell following recognition of PAMPS by Toll-like recep-
tors (TLRs). This makes it possible that constant exposure to 
gut microbiota could deliver sustained activation autophagy of 
gastrointestinal APCs and other cells with TLR receptors. A 
screen for PAMPS able to activate autophagy through TLRs of 
phagocytic cells has shown potent activation following recogni-
tion of single stranded RNA by TLR7.81 TLR7 is mostly con-
fined to endocytic compartments and provides a defense against 
viral infection, as demonstrated by activation of plasmacytoid 
dendritic cells by TLR7 signaling during infection by vesicular 
stomatitis virus.76,205 Induction of autophagy by TLR7 ligands 
requires the MyD88 adaptor protein and activation may be 
mediated through displacement of Beclin 1 from Bcl-2 following 
binding of Beclin 1 to MyD88 and TRIF.206 Beclin 1 may also be 
released from Bcl-2 during TLR signaling following phosphory-
lation by JNK.207 Activation of autophagy by TLR7 accelerates 
elimination of Mycobacteria from macrophages81 showing that 
activation of TLR7 during viral infection can affect the outcome 
of bacterial infection. Bacterial products such as LPS have also 
been shown to activate autophagy via TLR4.82 TLR4 induction 
colonic epithelial cells, some of which express co-stimulatory 
molecules, are still effective at suppressing CD4+ T cell activa-
tion by professional APCs.184 IECs are also a source of immu-
nosuppressive cytokines such as TGFβ.185 By a variety of means, 
therefore, IECs can exert the global hypo-responsiveness that is 
characteristic of oral tolerance with the dysregulation of any of 
their pathways of suppression able to contribute to the uncon-
trolled inflammation seen in IBD.
One way in which IEC ability to induce or preserve mucosal 
T cell tolerance would be compromised is through perturbations 
in the processing and presentation of self antigens. Several lines 
of evidence suggest that autophagy pathways might be involved 
in intracellular antigen processing for MHC class II loading and 
considerable levels of autophagy have been observed in thymic 
epithelial cells and immature dendritic cells involved in cen-
tral and peripheral T cell tolerance induction, respectively.102,104 
Second, the activation of autophagy that invariably follows 
microbial infection has the potential to increase processing of 
host, microbial and dietary antigens by MHC class II pathways, 
and this may alter the spectrum of peptides presented to the 
immune system.
Activation of autophagy by bacteria. It has become clear that 
despite different intracellular niches, diverse bacterial pathogens 
can be engulfed by autophagosomes and delivered to lysosomes. 
Thus, autophagy acts as a defense against bacteria that are unable 
to tolerate lysosomes, and for these bacteria activation of auto-
phagy results in microbial degradation, increased class II anti-
gen presentation and decreased microbial yields. Bacteria can, 
however, survive if they are able to block autophagy or prevent 
delivery to lysosomes. Most Salmonella remain within modified 
phagosomes called Salmonella-containing vacuoles (SCV) and 
are unaffected by autophagy. Damage to the SCVs or release 
of bacteria into the cytosol, results in engulfment by auto-
phagosomes, delivery to lysosomes and bacterial destruction.186 
Shigella flexneri resides within the host cytosol and secretes 
the VirG protein that is required for actin-based motility and 
transfer to neighboring cells. VirG binds to Atg5 and activates 
autophagy, but virulent isolates survive because this interaction 
is masked by the Shigella IcsB protein.187 Listeria monocytogenes 
evades autophagosomes via ActA-dependent actin-based motility 
and by secreting bacterial phospholipases that may compromise 
the autophagosome membrane.188,189 Other bacteria have evolved 
to replicate in the lysosome, and in these cases bacteria may even 
activate autophagy to accelerate delivery to lysosomes, as seen for 
example with Coxiella burnetii.190 Francisella tularensis disrupt the 
phagosome membrane soon after cell entry and are engulfed by 
autophagosomes and delivered to lysosomes. Francisella tularensis 
is, however, resistant to degradation in lysosomes and activation 
of autophagy increases microbial replication.191 Thus, autophagy 
can protect the cell cytosol from infection, but is also subverted 
by specialized pathogens via specific virulence factors.
Activation of autophagy by viruses. Much of what we know 
about autophagy and viral infection comes from studies on her-
pes simplex virus where inhibition of autophagy by the viral 
ICP34.5 protein leads to neurovirulence192 and from studies of 
the positive-stranded RNA viruses such as picornaviruses and 
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mucosa217 and that increased numbers of E. coli are associated 
with the epithelial intestinal layer.219,222-224 Phenotypic charac-
terization of CD-associated E. coli, which are AIEC, shows that 
they are able to adhere to and invade intestinal epithelial cells, 
but also to survive and replicate within macrophages, leading 
to the secretion of high amounts of TNFα.225,226 Such invasive 
E. coli have been observed by many groups in Europe and the 
United States.222,227-231 Like other pathogenic E. coli strains, 
AIEC are potent pro-inflammatory inducers since the interac-
tion between bacteria and host cells activates several pathways 
which lead to NFκB activation, upregulated IL-8 expression 
and transmigration of polymorphonuclear leukocytes.228,232 This 
inflammatory response is thought to result from the interaction 
of flagellin with Toll-like receptor 5 (TLR5) and IPAF,233 but the 
roles of the NOD family are yet to be fully elucidated in these 
models. In contrast to many pathogens that escape from the nor-
mal endocytic pathway, CD-associated invasive E. coli are taken 
up by macrophages within phagosomes, which mature without 
diverting from the classical endocytic pathway and which share 
features with phagolysosomes.234 Because of their ability to sur-
vive and replicate within epithelial cells, we could hypothesize 
that these pathogenic bacteria possess mechanisms to circumvent 
the innate host response and survive under hostile intracellular 
conditions. So far, such factors have yet to be identified in AIEC, 
since these organisms lack canonical type III secretion for deliv-
ery of effector proteins to host cells. This is in contrast to Shigella 
spp. which shares a similar lifestyle within the host epithelium 
and for which virulence factors required for autophagy avoid-
ance have been identified.187 Further investigations are needed 
to determine whether AIEC can escape from or modulate auto-
phagy in order to survive and/or replicate and whether they could 
replicate at a higher level in host cells with altered autophagy. 
Recent data suggest that AIEC are subject to autophagic con-
trol within epithelial cells, and that this process is influenced by 
ATG16L1 genotype.235
Despite these findings, it remains unclear whether such altera-
tions in flora represent a proximal cause of inflammation, or are a 
consequence of disease. Such inflammation-induced shifts in the 
gut flora have been observed following infection in mouse mod-
els, with both Citrobacter rodentium and Salmonella typhimurium 
infection promoting growth of Enterobacteriaceae.236,237
E. coli overgrowth could also be due to abnormal expression 
of host molecules acting as receptors for bacterial adhesion. In 
CD patients with ileal involvement of the disease, Barnich et 
al. recently observed an abnormal ileal expression of carcinoem-
bryonic antigen-related cell adhesion molecule 6 (CEACAM6) 
and showed that CEACAM6 acts as a very efficient recep-
tor mediating binding of pathogenic CD-associated E. coli.238 
Interestingly, in vitro studies demonstrate that CEACAM6 
expression is increased in cultured intestinal epithelial cells not 
only after IFNγ or TNFα stimulation,239 but also after infection 
with AIEC bacteria, indicating that AIEC bacteria can promote 
their own colonization in CD patients.238 In addition, using the 
transgenic CEABAC10 mice expressing human CEACAM6,240 
the Darfeuille-Michaud laboratory showed that CD-associated 
AIEC bacteria can colonize the intestinal mucosa and induce gut 
of autophagy requires class III PtdIns 3-kinases and p38 MAPK. 
TLR4 signaling also upregulates LRG47 GTPase, and in com-
mon with TLR7, increases elimination of Mycobacteria from 
macrophages.82
Activation of autophagy following TLR signaling from 
phagosomes has also been studied using TLR ligands immo-
bilized on latex beads.77 Beads bound to synthetic bacterial 
lipopeptides (Pam
3
CSK
4
, TLR1/2), zymosan (TLR2) or LPS 
(TLR4) stimulate autophagy and caused rapid recruitment of 
Beclin 1, PtdIns 3-kinase activity and LC3 to the phagosome 
membrane. Recruitment is dependent on Atg5 and Atg7, and 
results in increased fusion of LC3 with lysosomes; even so it was 
not possible to detect double-membraned vesicles associated with 
phagosomes. This makes it possible that TLR signaling results 
in direct recruitment of LC3 and PtdIns 3-kinase activity from 
the cytosol to the phagosome membrane to facilitate fusion with 
lysosomes to enhance elimination of incoming microorganisms. 
This may also be the case for Nod2, indicating that autophagy 
may be a general response to PAMP-derived signals that serves as 
an anti-infection mechanism.
The Microbial Hypothesis of IBD
CD has several features reminiscent of a microbial or infectious 
process in the gut114,208,209 and this has led many investigations into 
finding the potential infectious agent responsible. Mycobacterium 
avium subspecies paratuberculosis (MAP) was perhaps the bac-
terium with the longest history as a putative pathogenic role in 
CD.210,211 MAP had been initially favored as a candidate patho-
gen because there are clinical similarities between Johne disease, 
a spontaneous MAP infection in ruminants and CD. In the past 
few decades, several dozen published studies have provided evi-
dence that both supports and disputes the association of MAP 
with CD.210,212,213 However there remains no direct evidence that 
MAP plays a causal role in human CD and despite the establish-
ment of culture-free molecular tools for microbial identification, 
MAP has not been observed in the majority of CD or IBD cases. 
Similar cases have been made for other putative IBD-associated 
pathogens, including Listeria monocytogenes and Yersinia spp., 
but again evidence has been lacking, despite some circumstantial 
observations.214-216
What has become evident is that IBD patients exhibit an 
intestinal dysbiosis (microbial imbalance)—studies of lumenal 
bacterial composition in patients with IBD using both culture 
and molecular biological techniques have provided evidence 
for a decrease in beneficial bacteria such as the Bifidobacteria, 
Lactobacilli and Firmicutes and an increase in putative patho-
genic bacteria such as Bacteroides and Escherichia coli.217-220 This 
dysbiosis may promote inflammation by inducing a breakdown 
in the balance between putative protective versus harmful intesti-
nal bacteria. Indeed, a recent study showed that a low proportion 
of Faecalibacterium prausnitzii, bacteria with high anti-inflam-
matory properties, is associated with endoscopic recurrence at 
6 months on resected ileal Crohn mucosa.221 In addition, vari-
ous studies in CD patients reported that high concentrations of 
bacteria forming a biofilm are found on the surface of the gut 
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new molecular microbiological tools, in subsets of patients with 
known predisposing Atg16L1, IRGM and Nod2 polymorphisms 
are needed to determine the extent of correlation between colo-
nization/infection with particular microbial agents and CD. It 
would be of utility to begin such studies in affected families prior 
to onset of overt disease in order to examine the longitudinal 
variation of the flora and attempt to establish a baseline, pre-
disease “map” of the gut microbiota for comparison with later 
putative dysbioses.
Prior to the identification of the role of autophagy in CD, 
it was known that the bacterial flora played a crucial role in 
disease pathogenesis, but no single cellular pathway had been 
identified which might confer the immune regulatory defects 
seen in patients. Now autophagy integrates several aspects of 
CD pathogenesis including: known Nod2 associations; innate 
immune activation; defects in bacterial handling and antigen 
presentation; and the homeostasis of the epithelial barrier. Thus, 
autophagy provides a defined pathway with which to study the 
interaction of host and gut flora and how this is perturbed in 
disease states.
inflammation (Carvalho et al. manuscript submitted). Perhaps 
some of these questions may be answered in longitudinal metage-
nomic studies of large cohorts, but such efforts are only just get-
ting underway.
The implication of the Nod2-autophagy-innate immune axis 
through genetic studies have strengthened the idea that AIEC, 
but also other as-yet unidentified microbes such as enteric viruses, 
could be candidates for a role in CD. The basis of these assump-
tions rests upon the imputed host genetic susceptibility due to 
impaired function in host defense against intracellular bacteria, 
induced by polymorphisms in pathogen sensing and innate effec-
tor systems, such as Nod2 and autophagy.
Despite years of study, bacterial/CD correlations in humans 
have not yet approached fulfilling Hill’s criteria for causation;241 
however, recent work demonstrating norovirus-autophagy inter-
actions in an Atg16L1-hypomorphic mouse model of IBD shows 
promise in beginning to define specific pathogenic interactions in 
susceptible hosts.242 With current high-throughput technologies 
and large, genotyped patient cohorts it may be possible to iden-
tify putative initiating agents for further testing. Studies using 
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